Topical corticosteroid-induced adrenocortical insufficiency: Clinical implications

American Journal of Clinical Dermatology

Volumn 3, Issue 3, 2002, Pages 141-147

  Levin, Cheryl ^a   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; CORTICOSTEROID; CORTICOTROPIN; DESONIDE; DESOXIMETASONE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; HALCINONIDE; HYDROCORTISONE; TRIAMCINOLONE ACETONIDE;

ADRENAL CORTEX INSUFFICIENCY; ADRENAL FUNCTION; ADRENAL SUPPRESSION; AWARENESS; CLINICAL EXAMINATION; CORTICOTROPIN TEST; CREAM; DIAGNOSTIC TEST; DRUG POTENCY; EVALUATION; HIGH RISK POPULATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN TOLERANCE TEST; LABORATORY DIAGNOSIS; LONG TERM CARE; MEASUREMENT; OINTMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN DISEASE;

EID: 0036094625     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200203030-00001     Document Type: Review

References (57)

1. Suppression of the pituitary ACTH response in man by administration of ACTH or cortisol
2. Adrenocortical insufficiency
3. Comparison of hypothalamus-pituitary-adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas-chromatographic mass-spectrometry
4. Superpotent topical steroid treatment of psoriasis vulgaris: Clinical efficacy and adrenal function
5. Systemic absorption of topical steroids: Metabolic effects as an index of mild hypercortisolism
6. Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids
7. Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease
8. Adrenocortical response to adrenocorticotropic hormone in relation to duration of topical therapy and percutaneous absorption of hydrocortisone in children with dermatitis
9. Systemic effects of topically applied methylprednisolone aceponate in healthy-volunteers
10. Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis
11. Studies on the efficacy and adrenal effects of diprolene ointment 0.05 percent and dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses
12. Adrenal suppression following low-dose topical clobetasol propionate
13. Adrenocortical suppression by topical application of glucocorticosteroids in infants with seborrheic dermatitis
14. Corticosteroids and adrenal suppression: Characterising and avoiding the problem
15. Potency and duration of action of glucocorticoids: Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function
16. Corticosteroid therapy
17. A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man
18. Characterization of the glucocorticoid receptor in human epidermis and dermis
19. Method for comparing percutaneous absorbtion of steroids
20. Penetration of drugs through the skin
21. The use of corticosteroids in dermatological practice
22. Topical glucocorticoids
23. Effect of phonophoresis with dexamethasone on adrenal function
24. Plasma-cortisol studies with 0.05-percent halometasone cream and ointment in patients with psoriasis
25. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis
26. Adrenal function following topical steroid treatment in children with atopic dermatitis
27. Effect on plasma cortisol level and urinary cortisol excretion in healthy volunteers, after application of three different topical steroid ointments under occlusion
28. Adverse effects of topical corticosteroids
29. Absorption of a topical steroid and evaluation of adrenal suppression in patients with erosive lichen planus
30. Adverse effects of topical corticosteroid use
31. Percutaneous absorption of hydrocortisone increases with long-term administration: In vivo studies of the rhesus monkey
32. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone
33. Penetration of 14C hydrocortisone through normal skin: The effect of stripping and occlusion
34. Percutaneous absorption of corticosteroids: Adrenocortical suppression with total body inunction
35. In vivo percutaneous penetration
36. Topical corticosteroid therapy and its effect on the hypothalamic-pituitary-adrenal axis
37. Percutaneous absorption of testosterone in the newborn rhesus monkey
38. The absorption of topical corticosteroids with particular reference to percutaneous absorption in infants and childhood
39. Efficacy vs systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood
40. Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children
41. In vivo percutaneous absorption of hydrocortisone in psoriatic patients and normal volunteers
42. Regional variation in percutaneous penetration of 14-C cortisol in man
43. Glucocorticoids and adrenal androgens
44. Reproducibility of the cortisol response to stimulation with low dose of ACTH(1-24): The effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics
45. Clinical efficacy and tolerability of clobetasone 17-butyrate 0.5-percent lotion in children with atopic-dermatitis
46. Adrenocortical function in patients with severe atopic dermatitis
47. Adrenal diseases
48. Effect of diphenylhydantoin on the metabolism of dexamethasone: Mechanism of the abnormal dexamethasone suppression in humans
49. The noxious effects of steroids in local application
50. Adrenal axis suppression caused by a small dose of a potent topical corticosteroid
51. Super potent topical corticosteroid use associated with adrenal suppression: Clinical considerations
52. Cushing's syndrome after topical application of corticosteroids
53. Cushing syndrome from percutaneous absorption of triamcinolone cream
54. Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate
55. Fatal iatrogenic cushing's syndrome